BR0210143A - Fragmento de anticorpo recombinante, molécula de ácido nucleico, sequência de nucleotìdeo, processo para identificar fragmentos de anticorpo recombinante, uso do mesmo, preparação de agonistas contra a atividade biológica do ibdv, método para identificar um fragmento de anticorpo de ibdv recombinante, método para detectar a presença de anticorpo de ibdv em uma amostra, uso do mesmo, vetor, célula hospedeira recombinante, método para preparar um polipeptìdeo de anticorpo relacionado com o ibdv, conjunto para o diagnóstico de cepa do ibdv, composição terapêutica, método para tratar uma doença de ibdv, uso dos fragmentos de anticorpo recombinante - Google Patents
Fragmento de anticorpo recombinante, molécula de ácido nucleico, sequência de nucleotìdeo, processo para identificar fragmentos de anticorpo recombinante, uso do mesmo, preparação de agonistas contra a atividade biológica do ibdv, método para identificar um fragmento de anticorpo de ibdv recombinante, método para detectar a presença de anticorpo de ibdv em uma amostra, uso do mesmo, vetor, célula hospedeira recombinante, método para preparar um polipeptìdeo de anticorpo relacionado com o ibdv, conjunto para o diagnóstico de cepa do ibdv, composição terapêutica, método para tratar uma doença de ibdv, uso dos fragmentos de anticorpo recombinanteInfo
- Publication number
- BR0210143A BR0210143A BR0210143-2A BR0210143A BR0210143A BR 0210143 A BR0210143 A BR 0210143A BR 0210143 A BR0210143 A BR 0210143A BR 0210143 A BR0210143 A BR 0210143A
- Authority
- BR
- Brazil
- Prior art keywords
- ibdv
- recombinant
- antibody
- identifying
- antibody fragment
- Prior art date
Links
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title abstract 7
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 7
- 239000000556 agonist Substances 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 239000002773 nucleotide Substances 0.000 title abstract 2
- 230000004071 biological effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 241000702626 Infectious bursal disease virus Species 0.000 abstract 4
- 230000000890 antigenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"FRAGMENTO DE ANTICORPO RECOMBINANTE, MOLéCULA DE áCIDO NUCLEICO, SEQuêNCIA DE NUCLEOTìDEO, PROCESSO PARA IDENTIFICAR FRAGMENTOS DE ANTICORPO RECOMBINANTE, USO DO MESMO, PREPARAçãO DE AGONISTAS CONTRA A ATIVIDADE BIOLóGICA DO IBDV, MéTODO PARA IDENTIFICAR UM FRAGMENTO DE ANTICORPO DE IBDV RECOMBINANTE, MéTODO PARA DETECTAR A PRESENçA DE ANTICORPO DE IBDV EM UMA AMOSTRA, USO DO MESMO, VETOR, CéLULA HOSPEDEIRA RECOMBINANTE, MéTODO PARA PREPARAR UM POLIPEPTìDEO DE ANTICORPO RELACIONADO COM O IBDV, CONJUNTO PARA O DIAGNóSTICO DE CEPA DO IBDV, COMPOSIçãO TERAPêUTICA, MéTODO PARA TRATAR UMA DOENçA DE IBDV, USO DOS FRAGMENTOS DE ANTICORPO RECOMBINANTE". Um fragmento de anticorpo recombinante tendo uma especificidade de ligação para um determinante antigênico de IBDV.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR5468A AUPR546801A0 (en) | 2001-06-05 | 2001-06-05 | Recombinant antibodies |
| PCT/AU2002/000729 WO2002098921A1 (en) | 2001-06-05 | 2002-06-05 | Recombinant antibodies against infectious bursal disease virus (ibdv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210143A true BR0210143A (pt) | 2004-04-06 |
Family
ID=3829445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210143-2A BR0210143A (pt) | 2001-06-05 | 2002-06-05 | Fragmento de anticorpo recombinante, molécula de ácido nucleico, sequência de nucleotìdeo, processo para identificar fragmentos de anticorpo recombinante, uso do mesmo, preparação de agonistas contra a atividade biológica do ibdv, método para identificar um fragmento de anticorpo de ibdv recombinante, método para detectar a presença de anticorpo de ibdv em uma amostra, uso do mesmo, vetor, célula hospedeira recombinante, método para preparar um polipeptìdeo de anticorpo relacionado com o ibdv, conjunto para o diagnóstico de cepa do ibdv, composição terapêutica, método para tratar uma doença de ibdv, uso dos fragmentos de anticorpo recombinante |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7449556B2 (pt) |
| EP (1) | EP1399481A4 (pt) |
| AU (1) | AUPR546801A0 (pt) |
| BR (1) | BR0210143A (pt) |
| CA (1) | CA2449132A1 (pt) |
| MX (1) | MXPA03011117A (pt) |
| NZ (1) | NZ529677A (pt) |
| WO (1) | WO2002098921A1 (pt) |
| ZA (1) | ZA200309126B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003054021A2 (en) * | 2001-12-20 | 2003-07-03 | Agricultural Research Council | Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes |
| DE602005018477D1 (de) * | 2005-08-26 | 2010-02-04 | Pls Design Gmbh | Bivalente IgY Antikörperkonstrukte für diagnostische und therapeutische Anwendungen |
| US20100323905A1 (en) * | 2005-09-23 | 2010-12-23 | Academisch Ziekenhuis Leiden | Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates |
| WO2008083432A1 (en) * | 2007-01-08 | 2008-07-17 | Biosecurity Innovation Pty Ltd | Recombinant antibodies |
| KR20170084086A (ko) | 2014-11-17 | 2017-07-19 | 아르노 테라퓨틱스 인코포레이티드 | 오나프리스톤 연장-방출 조성물 및 방법 |
| US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
| CN108484759A (zh) * | 2018-03-01 | 2018-09-04 | 东北农业大学 | 两种scFv抗体、其编码基因及其在制备治疗或预防鸡传染性法氏囊病制剂中的应用 |
| EP3793614A4 (en) * | 2018-04-30 | 2022-04-20 | Integral Molecular, Inc. | GLUCOSE TRANSPORTER-4 ANTIBODIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USES |
| CN110878123B (zh) * | 2018-09-05 | 2022-08-23 | 华瑞同康生物技术（深圳）有限公司 | 一种抗tk1原核重组单链抗体及制备方法 |
| WO2020168024A1 (en) | 2019-02-15 | 2020-08-20 | Integral Molecular, Inc. | Antibodies comprising a common light chain and uses thereof |
| CA3129834A1 (en) | 2019-02-15 | 2020-08-20 | Integral Molecular, Inc. | Claudin 6 antibodies and uses thereof |
| CN110456047B (zh) * | 2019-09-09 | 2023-05-02 | 江苏省农业科学院 | 一种传染性法氏囊病病毒抗体竞争elisa检测方法及试剂盒 |
| CN113402603B (zh) * | 2021-06-09 | 2022-05-03 | 陕西理工大学 | 一种抗SARS-CoV-2病毒S1蛋白的禽源单链抗体及其应用 |
| CN117843771B (zh) * | 2021-12-13 | 2024-09-03 | 东北农业大学 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| US12049502B2 (en) | 2022-11-30 | 2024-07-30 | Integral Molecular, Inc. | Antibodies directed to claudin 6, including bispecific formats thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| EP0088046B1 (de) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| JPS607934A (ja) | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソ−ムの製造方法 |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3483949D1 (de) | 1983-09-26 | 1991-02-21 | Udo Dr Med Ehrenfeld | Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr. |
| EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| US4956452A (en) * | 1987-06-14 | 1990-09-11 | The University Of Maryland | Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus |
| WO1990015140A1 (en) | 1989-05-30 | 1990-12-13 | Commonwealth Scientific And Industrial Research Organisation | Production of ibdv vp2 in highly immunogenic form |
| AU7955591A (en) | 1990-05-04 | 1991-11-27 | University Of Maryland At College Park, The | Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5605792A (en) * | 1993-11-04 | 1997-02-25 | The Ohio State University Research Foundation | Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic |
| US6528063B2 (en) * | 1999-01-04 | 2003-03-04 | Rahan Meristem | Recombinant vaccines against IBDV |
| WO2001062907A1 (en) * | 2000-02-22 | 2001-08-30 | Medical & Biological Laboratories Co., Ltd. | Antibody library |
-
2001
- 2001-06-05 AU AUPR5468A patent/AUPR546801A0/en not_active Abandoned
-
2002
- 2002-06-05 US US10/479,670 patent/US7449556B2/en not_active Expired - Fee Related
- 2002-06-05 WO PCT/AU2002/000729 patent/WO2002098921A1/en not_active Application Discontinuation
- 2002-06-05 BR BR0210143-2A patent/BR0210143A/pt not_active IP Right Cessation
- 2002-06-05 CA CA002449132A patent/CA2449132A1/en not_active Abandoned
- 2002-06-05 EP EP02776498A patent/EP1399481A4/en not_active Withdrawn
- 2002-06-05 MX MXPA03011117A patent/MXPA03011117A/es not_active Application Discontinuation
- 2002-06-05 NZ NZ529677A patent/NZ529677A/en unknown
-
2003
- 2003-11-24 ZA ZA200309126A patent/ZA200309126B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1399481A1 (en) | 2004-03-24 |
| US7449556B2 (en) | 2008-11-11 |
| ZA200309126B (en) | 2004-11-24 |
| WO2002098921A1 (en) | 2002-12-12 |
| CA2449132A1 (en) | 2002-12-12 |
| AUPR546801A0 (en) | 2001-06-28 |
| US20040141980A1 (en) | 2004-07-22 |
| MXPA03011117A (es) | 2004-03-19 |
| NZ529677A (en) | 2006-05-26 |
| EP1399481A4 (en) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210143A (pt) | Fragmento de anticorpo recombinante, molécula de ácido nucleico, sequência de nucleotìdeo, processo para identificar fragmentos de anticorpo recombinante, uso do mesmo, preparação de agonistas contra a atividade biológica do ibdv, método para identificar um fragmento de anticorpo de ibdv recombinante, método para detectar a presença de anticorpo de ibdv em uma amostra, uso do mesmo, vetor, célula hospedeira recombinante, método para preparar um polipeptìdeo de anticorpo relacionado com o ibdv, conjunto para o diagnóstico de cepa do ibdv, composição terapêutica, método para tratar uma doença de ibdv, uso dos fragmentos de anticorpo recombinante | |
| PL404537A1 (pl) | Wirusy stowarzyszone z adenowirusem, kompozycje, wyizolowane bialko kapsydu, wyizolowana lub syntetyczna czasteczka kwasu nukleinowego, sposób wytwarzania rekombinowanych wirusów, komórki gospodarza, bialka obejmujace fragment bialka kapsydu AAV, sztuczne bialka, rekombinowane wirusy, czasteczki, sposoby dostarczania transgenu do komórki, sposób identyfikacji serotypu sekwencji wirusa (AAV), zestaw diagnostyczny, sposób izolacji nowych wirusów, nowe serotypy wirusa, wyizolowane wirusy, rekombinowana komórka, zastosowanie wirusa | |
| BR9917218A (pt) | Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas | |
| BR0016569A (pt) | Processo de isolamento de rna de espécimes de tecido embutidos - parafina fixados - formalina | |
| BRPI0612273B8 (pt) | anticorpo de ligação a il-1 beta ou fragmento de ligação a il-1 beta do mesmo, ácido nucleico, vetor, e, composição | |
| JP2005504513A5 (pt) | ||
| KR20080114683A (ko) | 질병에 대한 바이오마커로서의 지방생성 아데노바이러스 | |
| Gupta et al. | Probing interactions between CLIP-170, EB1, and microtubules | |
| BRPI0214188B8 (pt) | anticorpo ou fragmento do mesmo, molécula de ácido nucléico, uso do anticorpo monoclonal ou fragmento do mesmo, kit de diagnóstico, composição farmacêutica, vetor de expressão recombinante, célula hospedeira transformada com o vetor de expressão recombinante e método para detectar o antígeno do vírus da hepatite e ou o anticorpo contra o vírus da hepatite e em uma amostra | |
| SE9500023D0 (sv) | Method of detecting cancer | |
| JP2009540852A5 (pt) | ||
| BR9803960A (pt) | Gene de desidrogenase de d-sorbitol. | |
| CN1045603A (zh) | 筛选系统 | |
| Moore et al. | Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene. | |
| EP0918865B1 (de) | Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe | |
| ATE315648T1 (de) | Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure | |
| Bermek | Mechanisms of protein synthesis: structure-function relations, control mechanisms, and evolutionary aspects | |
| EA200000845A1 (ru) | Ген, кодирующий новый маркер рака | |
| CN110305963B (zh) | 一种食管癌分子标志物及其应用 | |
| WO1998018822A3 (en) | Novel human lim proteins | |
| Kazemie | Binding of Aminoacyl‐tRNA to Reconstituted Subparticles of Escherichia coli Large Ribosomal Subunits | |
| Larouche et al. | Optimization of competitor poly (dI-dC)• poly (dI-dC) levels is advised in DNA-protein interaction studies involving enriched nuclear proteins | |
| BR9910725A (pt) | Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14 | |
| BR0010479A (pt) | Gene tipo prp | |
| RU2010136820A (ru) | Новый белок fer-типа, содержащая его фармацевтическая композиция и способ его использования |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |